Viatris Inc. (FRA:VIA)

Market Cap	15.56B +24.1%
Revenue (ttm)	12.04B -6.1%
Net Income	-3.15B
EPS	-2.66
Shares Out	n/a
PE Ratio	n/a
Forward PE	6.44
Dividend	0.42 (3.14%)
Ex-Dividend Date	Nov 24, 2025

Volume	2
Average Volume	552
Open	13.54
Previous Close	13.33
Day's Range	13.54 - 13.54
52-Week Range	0.01 - 13.60
Beta	n/a
RSI	71.73
Earnings Date	Feb 26, 2026

About Viatris

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN...

• Industry: Pharmaceutical Preparations
• Founded: 1961
• Employees: 30,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: VIA

Financial Performance

Financial numbers in USD